DECREASING PATTERNS OF INFLIXIMAB TROUGH LEVELS IN ASYMPTOMATIC INFLAMMATORY BOWEL DISEASE PATIENTS UNDER MAINTENANCE TREATMENT WITH INFLIXIMAB; DOES IT MATTER?

被引：0
|
作者：
Orfanoudaki, Eleni
Gazouli, Maria
Foteinogiannopoulou, Kalliopi
Theodoraki, Eirini
Legaki, Evangelia
Koutroubakis, Ioannis E.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1890
引用
收藏
页码：S467 / S467
页数：1
相关论文
共 50 条
  • [41] SERUM INFLIXIMAB LEVELS,ANTIBODIES TO INFLIXIMAB AND ALBUMIN CONCENTRATIONS DURING INFLIXIMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Malickova, K.
    Janatkova, I.
    Duricova, D.
    Bortlik, M.
    Lukas, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 213 - 213
  • [42] Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease
    Guiotto, Cristina
    Daperno, Marco
    Frigeri, Francesco
    Vizzini, Margherita
    Cerruti, Roberta
    Ercole, Elena
    Cosimato, Maurizio
    Lavagna, Alessandro
    Germano, Laura
    Migliardi, Marco
    Rocca, Rodolfo
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (02) : 138 - 143
  • [43] ROLE OF TROUGH LEVELS AND ANTIBODIES TO INFLIXIMAB IN THE EVALUATION OF LOSS OF RESPONSE AND INFUSION REACTIONS TO INFLIXIMAB THERAPY IN INFLAMMATORY BOWEL DISEASE
    Marzo, M.
    Armuzzi, A.
    Felice, C.
    Pugliese, D.
    Andrisani, G.
    Tolusso, B.
    Gremese, E.
    De Vitis, I.
    Rapaccini, G. L.
    Papa, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S77 - S77
  • [44] Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn's Disease
    Kang, Ben
    Choi, So Yoon
    Choi, Young Ok
    Lee, Soo-Youn
    Baek, Sun-Young
    Sohn, Insuk
    Choe, Byung-Ho
    Lee, Hae Jeong
    Choe, Yon Ho
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (02): : 189 - 197
  • [45] Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
    Choi, So Yoon
    Kang, Ben
    Lee, Jee Hyun
    Choe, Yon Ho
    GUT AND LIVER, 2017, 11 (01) : 55 - 61
  • [46] Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population
    Dipasquale, Valeria
    Alibrandi, Angela
    Pellegrino, Salvatore
    Ramistella, Vincenzo
    Romano, Claudio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (02) : 237 - 244
  • [47] High infliximab trough levels are associated with better control of inflammation in inflammatory bowel disease
    Drobne, D.
    Kurent, T.
    Rajar, P.
    Slak, M.
    Kozelj, M.
    Novak, G.
    Smrekar, N.
    Plut, S.
    Smid, A.
    Osredkar, J.
    Stabuc, B.
    Ferkolj, I.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S249 - S250
  • [48] Large Variation in Infliximab Trough Levels Is Associated With Disease Activity in Paediatric Inflammatory Bowel Disease
    Hoekman, Danil R.
    Brandse, Johannan F.
    de Meij, Tim
    Hummel, Thalia
    Lowenberg, M.
    Benninga, Marc A.
    D'Haens, Geert R.
    Kindermann, Angelika
    GASTROENTEROLOGY, 2014, 146 (05) : S782 - S782
  • [49] THE CLINICAL AND FINANCIAL IMPACT OF MEASURING INFLIXIMAB LEVELS AND ANTIBODIES TO INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS
    O'Reilly, S.
    Keegan, D.
    Byrne, K.
    Sheridan, J.
    Mulcahy, H. E.
    Doherty, G. A.
    Cullen, G.
    GUT, 2017, 66 : A2 - A3
  • [50] Large variation in infliximab trough levels is associated with disease activity in paediatric inflammatory bowel disease
    Hoekman, D.
    Brandse, H.
    de Meij, T.
    Hummel, T.
    Loewenberg, M.
    Benninga, M.
    D'Haens, G.
    Kindermann, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S35 - S35
12345